High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
出版年份 2015 全文链接
标题
High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
作者
关键词
c-Met, Colorectal cancer, Prognosis, Meta-analysis
出版物
TUMOR BIOLOGY
Volume 36, Issue 2, Pages 515-520
出版商
Springer Nature
发表日期
2015-01-31
DOI
10.1007/s13277-014-2659-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.
- (2017) E. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- Multivariate Analysis of Molecular Indicators for Postoperative Liver Metastasis in Colorectal Cancer Cases
- (2013) Li-Yuan Qian et al. Asian Pacific Journal of Cancer Prevention
- c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
- (2013) Shan Yu et al. PLoS One
- Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis—correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met
- (2013) Alexandros Garouniatis et al. TUMOR BIOLOGY
- FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
- (2012) Alexandros Garouniatis et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation
- (2012) Abbas K. Samadi et al. TUMOR BIOLOGY
- Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma
- (2011) Shahab Uddin et al. AMERICAN JOURNAL OF PATHOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
- (2011) Alessandro Inno et al. Clinical Colorectal Cancer
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer
- (2009) Hua-Jun Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
- (2009) Andrea Sartore-Bianchi et al. PLoS One
- c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases
- (2008) Zhao-Shi Zeng et al. CANCER LETTERS
- The Relative Distribution of Membranous and Cytoplasmic Met Is a Prognostic Indicator in Stage I and II Colon Cancer
- (2008) F. Ginty et al. CLINICAL CANCER RESEARCH
- Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
- (2008) L. Toschi et al. CLINICAL CANCER RESEARCH
- The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer
- (2008) Chung-Ta Lee et al. DISEASES OF THE COLON & RECTUM
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started